⌘K

Home/Filings/4/0001415889-24-029471

4//SEC Filing

Bernstein Karen 4

Accession 0001415889-24-029471

CIK 0001636651other

View on SEC.gov Company Profile

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 4:15 PM ET

Size

11.2 KB

Accession

0001415889-24-029471

Insider Transaction Report

Form 4

Period: 2024-12-12

Ovid Therapeutics Inc.OVID

Bernstein Karen

Director

Transactions

Award
Stock Option (Right to Buy)
2024-12-12+90,000→ 90,000 total
Exercise: $1.06Exp: 2034-12-11→ Common Stock (90,000 underlying)

Footnotes (1)

[F1]The shares will vest in 36 equal monthly installments, subject to the Reporting Person's continued services through such date.

Documents

2 files

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1

filerCIK 0001654055

Filing Metadata

Form type: 4
Filed: Dec 15, 7:00 PM ET
Accepted: Dec 16, 4:15 PM ET
Size: 11.2 KB

View on SEC.gov